Insulet Corp (NASDAQ:PODD)
| 244.27 Delayed Data As of Oct 04 |  +11.30 / +4.85%Today’s Change | 181.00 Today|||52-Week Range 324.81 | -8.19% Year-to-Date |
Latest PODD News | Press Releases
No recent news for Insulet Corp.
Today’s Trading
| Previous close | 232.97 |
| Today’s open | 239.28 |
| Day’s range | 238.37 - 244.87 |
| Volume | 308,921 |
| Average volume (3 months) | 428,062 |
| Market cap | $15.9B |
Data as of 4:00pm ET, 10/04/2022
Growth & Valuation
| Earnings growth (last year) | +136.38% |
| Earnings growth (this year) | +84.10% |
| Earnings growth (next 5 years) | +92.10% |
| Revenue growth (last year) | +21.49% |
| P/E ratio | 469.8 |
| Price/Sales | 16.61 |
| Price/Book | 28.52 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SAUHFStraumann Holding AG | +8.42 | +9.49% |
| WSTWest Pharmaceutical ... | -0.45 | -0.17% |
| ABMDABIOMED Inc | +8.86 | +3.47% |
| ZBHZimmer Biomet Holdin... | -0.03 | -0.03% |
Data as of 4:00pm ET, 10/04/2022
Financials
| Next reporting date | November 4, 2022 |
| EPS forecast (this quarter) | $0.16 |
| Annual revenue (last year) | $1.1B |
| Annual profit (last year) | $16.8M |
| Net profit margin | 1.53% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Acton, Massachusetts |
Forecasts
